Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 7.20
+0.19 (2.71%)
Oct 27, 2026, 4:10 PM AEDT
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 363.08 million as of October 27, 2026. It is the 19,225th most valuable company in the world and the 357th biggest in Australia. Its market cap has decreased by 37.60% in one year.
Market Cap
363.08M
Enterprise Value
112.96M
Revenue
94.02M
Global Rank
Country Rank
#357 Australia
PE Ratio
10.78
ChartMarket Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 363.08M, an increase of 6,848.03%. That is a compound annual growth rate of 17.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 363.08M | -41.95% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 585.74M |
| Racura Oncology | 310.77M |
| Tetratherix | 272.19M |
| Starpharma Holdings | 223.08M |
| BLS Pharmaceuticals | 215.33M |
| Actinogen Medical | 177.00M |
| Paradigm Biopharmaceuticals | 153.48M |
| Orthocell | 140.28M |